A global phase 2 study including efficacy, safety and patient-reported outcomes (PROs) with crizotinib in patients (Pts) with ALK-positive non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Kim, D. W.; Blackhall, F.; Soria, J. C.; Solomon, B.; Camidge, D. R.; Riely, G. J.; Bottomley, A.; Tassell, V.; Polli, A.; Shaw, A. |
| Abstract Title: | A global phase 2 study including efficacy, safety and patient-reported outcomes (PROs) with crizotinib in patients (Pts) with ALK-positive non-small cell lung cancer (NSCLC) |
| Meeting Title: | 16th ECCO - 36th ESMO - 30th ESTRO European Multidisciplinary Cancer Congress (EMCC 2011) |
| Journal Title: | European Journal of Cancer |
| Volume: | 47 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2011 Sep 23-27 |
| Meeting Location: | Stockholm, Sweden |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2011-09-01 |
| Start Page: | S617 |
| Language: | English |
| ACCESSION: | WOS:000295752802191 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(11)72396-6 |
| Notes: | --- - Meeting Abstract 9084 - European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care - SEP 23-27, 2011 - Stockholm, SWEDEN - "Source: Wos" |
